Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS
· Delayed Price · Currency is USD
0.0493
+0.0033 (7.07%)
At close: Dec 5, 2025
Adaptimmune Therapeutics Employees
Adaptimmune Therapeutics had 506 employees as of December 31, 2024. The number of employees increased by 57 or 12.69% compared to the previous year.
Employees
506
Change (1Y)
57
Growth (1Y)
12.69%
Revenue / Employee
$128,626
Profits / Employee
-$335,486
Market Cap
13.05M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Adaptimmune Therapeutics News
- 19 days ago - Adaptimmune Announces Changes to Board and Executive Leadership Team - Newsfile Corp
- 6 weeks ago - Adaptimmune Announces Delisting from Nasdaq - Newsfile Corp
- 4 months ago - Adaptimmune Reports Q2 Financial Results and Provides Business Update - Newsfile Corp
- 4 months ago - Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds - Newsfile Corp
- 7 months ago - Adaptimmune Therapeutics plc (ADAP) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Adaptimmune Reports Q1 Financial Results and Provides Business Update - Newsfile Corp
- 7 months ago - Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025 - Newsfile Corp
- 9 months ago - Adaptimmune Therapeutics plc (ADAP) Q4 2024 Earnings Call Transcript - Seeking Alpha